ABA 0.00% $5.15 abano healthcare group limited

Ann: ASSET: ABA: Abano Dental Continues Growth an

  1. lightbulb Created with Sketch. 2
    • Release Date: 03/03/14 14:14
    • Summary: ASSET: ABA: Abano Dental Continues Growth and Surpasses 150 Milestone
    • Price Sensitive: No
    • Download Document  5.62KB
    					ABA
    03/03/2014 12:14
    ASSET
    
    REL: 1214 HRS Abano Healthcare Group Limited
    
    ASSET: ABA: Abano Dental Continues Growth and Surpasses 150 Milestone
    
    With its sixteenth dental acquisition in the first nine months of its
    financial year, Abano Healthcare Group (NZX:ABA) has achieved and surpassed a
    major milestone, with its dental group now totalling 151 practices across New
    Zealand and Australia. This firmly establishes Abano as the second largest
    and fastest growing dental corporate consolidator in Australasia.
    
    The listed healthcare company has been investing in the dental sector since
    2002 through its Lumino the Dentists business in New Zealand and through
    Dental Partners in Australia. The trans-Tasman acquisitions made to date in
    this financial year will provide additional annualised gross revenues of over
    AU$20million to Dental Partners and over NZ$4 million to Lumino.
    
    Abano's managing director, Alan Clarke, said: "Our dental business has been
    growing through acquisition and organic expansion for close to fifteen years.
    One hundred and fifty-one practices is a fantastic milestone to reach. We
    have some of the most experienced dental management teams and clinical
    expertise in the region and our people are a key ingredient in our success.
    
    "Our highly successful marketing programme for Lumino the Dentists in New
    Zealand has helped us drive same store growth over the past three years, in a
    market where the wider profession has seen an annual decline in revenue.
    Because of this success, we will soon be rolling out similar branded
    marketing initiatives in Australia.  Our strengthened Dental Partners
    management team, with a new CFO, GM Human Resources and soon to be added GM
    Marketing, will allow us to translate our New Zealand experience to Australia
    and maximise the potential of this remarkably large market as we continue to
    expand our Australian network."
    
    Alan Clarke continued: "Pleasingly, we have also achieved an overall lift in
    same store sales in our dental group for December 2013/January 2014, when
    compared to the previous year.
    
    "In New Zealand, this was over 3% same store growth for these two months, in
    what has been a declining market.  This is a reflection of Lumino's
    successful branding and marketing activity. Combined with innovative offers
    such as interest free funding and a growing online campaign, we have seen the
    business achieve large increases in areas such as new patient bookings and
    online appointment bookings, which translates into increased treatments and
    revenue.
    
    "The Australian dental market has been impacted in recent months due to the
    deterioration of the Australian economy and a downturn in consumer
    confidence. This was exacerbated by the removal of a Government funded
    Chronic Disease Dental Scheme in November 2012.  Due to these conditions,
    several dental consolidators are now reporting negative year on year growth.
    It is interesting to note that 1300 Smiles, an ASX-listed dental group which
    had previously indicated a large exposure to the Scheme, has just reported a
    30% drop in revenues and a 36% drop in reported profits.
    
    "Due to Abano's strategy to concentrate on private revenue sources, Dental
    Partners' exposure to the Scheme was limited, at around 5% of total revenues,
    with Dental Partners reporting a year on year decline in HY14 same store
    sales of just 8%.
    
    "Despite there being little improvement in the overall economy, Dental
    Partners has experienced a pleasing lift in recent months, with same store
    revenue for the December 13/January 14 period up 4% on the same time last
    year.  This follows management action with respect to client recall and local
    advertising.
    
     "As we introduce our new branding and marketing strategy into Australia, we
    expect to see this growth continue. The increasing scale and size of our
    Trans-Tasman dental group is also now starting to deliver a number of real
    commercial benefits, including increased negotiating power with suppliers and
    buying efficiencies."
    
    Abano first invested into the dental sector in late 2002, with the
    acquisition of a small group of dental practices, primarily located in
    Auckland. Since that time, the business has been rebranded as Lumino the
    Dentists and grown its New Zealand footprint to 78 practices, with more than
    644 staff, delivering over NZ$77 million in annualised gross revenues.
    
    Abano entered the Australian dental market in June 2008, in partnership with
    a local management team to form Dental Partners and take advantage of the
    growing acceptance of corporate consolidation in the dental sector. Abano
    acquired 100% of this business in 2012 and from an initial nine practices,
    Dental Partners now has 73 practices, with over 800 staff, delivering more
    than AU$105 million in annualised gross revenues.
    
    Alan Clarke said: "The NZ$9.6 billion Australasian dental market is expected
    to continue to grow over the mid to long term. The consolidation model is
    becoming more widely accepted by clinicians, and while dental consolidators
    currently own less than 5% of practices, we expect to see this change
    significantly going forward in line with the experience of more mature
    markets such as the USA.
    
    "Abano Dental has an established and excellent reputation within the dental
    profession and we are now the first choice for many vendor dentists who are
    considering joining a corporate consolidator.  We have an experienced and
    supportive management team, a strong clinical team and funding for innovative
    growth.
    
    "We are well positioned to continue the expansion of our networks in New
    Zealand and Australia, building a great organisation and delivering
    sustainable shareholder value for Abano in the years ahead."
    
    ENDS
    End CA:00247742 For:ABA    Type:ASSET      Time:2014-03-03 12:14:20
    				
 
watchlist Created with Sketch. Add ABA (NZSX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.